Seeing Is Believing
Currently out of the existing stock ratings of Catherine Novack, 55 are a BUY (96.49%), 2 are a HOLD (3.51%).
Analyst Catherine Novack, currently employed at JONESTRADING, carries an average stock price target met ratio of 33.92% that have a potential upside of 54.92% achieved within 136 days.
Catherine Novack’s has documented 105 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SEPN, Septerna at 13-Aug-2026.
Analyst best performing recommendations are on WVE (WAVE LIFE SCIENCES LTD).
The best stock recommendation documented was for WVE (WAVE LIFE SCIENCES LTD) at 9/3/2024. The price target of $12 was fulfilled within 43 days with a profit of $6.45 (116.22%) receiving and performance score of 27.03.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Dec-2020
$12
10 months 19 days ago
(02-Dec-2025)
1/6 (16.67%)
$9.16 (322.54%)
1042
Hold Since 04-Sep-2025
$8
$6.6 (471.43%)
1 years 1 months 17 days ago
(04-Sep-2025)
1/2 (50%)
$5.87 (275.59%)
2316
Buy Since 18-Aug-2025
$11
$9.6 (685.71%)
1 years 2 months 3 days ago
(18-Aug-2025)
1/2 (50%)
$8.89 (421.33%)
203
Buy Since 30-Nov-2022
$13
$11.6 (828.57%)
$5
2 years 2 months 5 days ago
(16-Aug-2024)
2/3 (66.67%)
$9.43 (264.15%)
149
Buy Since 13-Aug-2021
$2
$0.17 (9.29%)
$3
3 years 1 months 21 days ago
(30-Aug-2023)
4/4 (100%)
$-6.52 (-76.53%)
856
Which stock is Catherine Novack most bullish on?
Which stock is Catherine Novack most reserved on?
What Year was the first public recommendation made by Catherine Novack?